Carhart-Harris R

Serotonergic psychedelics delay resting state neurovascular coupling dynamics

Mundel L, Medel V, Timmermann C +9

PreprintKetamine

Neurite Complexity and Plasticity Markers Track Synaptic Vesicle Density in the Living Human Brain: A Multimodal PET-MRI-EEG Study

Agnorelli C, Peill J, Kurtin DL +25

Psychedelics restructure information in the human brain

Blackburne G, Liardi A, Mallaroni P +6

LSD reconfigures cortical dynamics through faster brain rhythms and increased fractal dimension.

Subramani V, Nest T, Pascarella A +8

Moving beyond 5-HT2A: language models map neurotransmitter receptors to experiential semantics.

Suresh P, Kins J, Levkovskyy L +6

Spiral brain dynamics track the temporal unfolding of subjective intensity during the N,N -dimethyltryptamine experience

Sawicka G, Martínez-Marín M, Timmermann C +5

Higher signal diversity, network dysregulation, and increased well-being under DMT administration: An EEG study.

Kroupi E, Araujo H, Oosterveld C +5

Tales of the unexpected: psychedelic trial design solutions

Carhart-Harris R, Lucas WA, Pasquini L +4

Micro-phenomenology of immersion and perceived presences under DMT.

Sanders JW, Millière R, Demšar E +4

Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes

Frick A, Blest-Hopley G, Grin M +3

A Shared Entropic Axis Spans States of Consciousness Across Pharmacological and Clinical Conditions

Galvan Rial DS, Della Bella GA, Naci L +8

Computational spirits: a neuroscientific account of psychedelic entity encounters.

Mago J, Deane G, Sandved-Smith L +7

Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.

Reid MJ, Kettner H, Blanken TF +2

On the meaning of ‘plasticity’ in neuroscience and mental health research and its relation to the action of psychedelic therapy

Carhart-Harris R, Zeifman R, Pasquini L +8

Effects of psychedelic use on authoritarian attitudes revisited.

Simonsson O, Lyons T, Marks J +5

The Allostatic Reset Model (ARM) of Psychedelic Action

Lawrence D, Brouwer A, Fabiano N +2

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.

Goodwin GM, Aaronson ST, Alvarez O +23

ArticleKetamine

Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Agnorelli C, Peill J, Sawicka G +18

The combination of exercise and psychedelics for the treatment of major depressive disorder.

Fabiano N, Stubbs B, Lawrence DW +5

Dorsal-ventral precuneus gradients organise large-scale networks and track consciousness level

Lu D, Ram A, Carhart-Harris R +5

LSD Relaxes Structural Constraints on Brain Dynamics: A Connectome Harmonic MEG Study

Subramani V, Pascarella A, Brunel J +6

Baseline Mood and "Relational Triad" Predict Acute Qualities of Psychedelic Experience.

Lipson J, Kettner H, Carhart-Harris R +1

Prospective real-world evidence of mental health outcomes following supervised psilocybin services within Oregon’s state-regulated model

Gow A, Shih E, Reid R +5

A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.

Erritzoe D, Barba T, Benway T +15

LSD Reconfigures Cortical Dynamics Through Faster Brain Rhythms and Increased Fractal Dimension

Subramani V, Nest T, Pascarella A +8

DMT-Induced Shifts in Criticality Correlate with Self-Dissolution.

Irrmischer M, Aqil M, Luan L +5

The entropic brain today

Carhart-Harris R

Defining ‘psychedelic’

Ostrand A, Nour M, Timmermann C +7

Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.

Purple RJ, Gupta R, Thomas CW +5

A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness.

Alnagger NLN, Cardone P, Martial C +15

Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.

Shinozuka K, Jerotic K, Mediano P +4

Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.

Martens MAG, Cunha BG, Erritzoe D +3

ArticleMDMA

Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.

Højlund M, Kafali HY, Kırmızı B +33

Eigenmodes of the deep unconscious: the neuropsychology of Jungian archetypes and psychedelic experience.

McGovern H, Aqil M, Atasoy S +1

Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].

Goodwin GM, Aaronson ST, Alvarez O +28

Cross-species mapping of psychedelic gene expression reveals links to the 5HT2A receptor, cortical layers, and human accelerated regions

McConnell P, Raffety J, Li A +6

Blunted psychedelic drug effects in older adults

Aday JS, Carhart-Harris R, Boehnke KF

Blunted psychedelic drug effects in older adults

Aday JS, Carhart-Harris R, Boehnke KF

Validation of the Imperial Psychedelic Predictor Scale - CORRIGENDUM.

Angyus M, Osborn S, Haijen E +5

Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.

Purple RJ, Gupta R, Thomas CW +5

Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion

Zeifman R, Danias G, Agin-Liebes G +6

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.

Blest-Hopley G, Pasculli G, Ruffell SGD +7

Perturbing whole-brain models of brain hierarchy: An application for depression following pharmacological treatment.

Socoró-Garrigosa M, Perl YS, Kringelbach ML +5

Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.

Calnan M, Blest-Hopley G, Busch C +6

Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.

Pellegrini L, Fineberg NA, O'Connor S +11

Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.

Harding R, Singer N, Wall MB +5

The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial.

Henry J, Giribaldi B, Nutt DJ +3

Micro-phenomenology of immersion and perceived presences under DMT

Sanders JW, Millière R, Demšar E +3

PreprintKetamine

Detecting neuroplastic effects induced by ketamine in healthy human subjects: a multimodal approach

Agnorelli C, Peill J, Sawicka G +16

Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.

Harding R, Singer N, Wall MB +5

Decreased CO2 saturation during circular breathwork supports emergence of altered states of consciousness.

Havenith MN, Leidenberger M, Brasanac J +12

Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.

Agnorelli C, Spriggs M, Godfrey K +8

The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State.

Coleman CR, Shinozuka K, Tromm R +7

LSD reconfigures the frequency-specific network landscape of the human brain

Shinozuka K, Rosso M, Coleman CR +8

The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial

Henry J, Giribaldi B, Nutt DJ +3

Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT).

Piccinini JI, Sanz Perl Y, Pallavicini C +6

Psychedelics Align Brain Activity with Context

Stoliker D, Novelli L, Khajehnejad M +16

Psilocybin for disorders of consciousness: A case-report study.

Cardone P, Núñez P, Alnagger NLN +5

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

Yaden DB, Graziosi M, Owen AM +39

Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors.

Jiwani Z, Goldberg SB, Stroud J +7

DMT-induced shifts in criticality correlate with ego-dissolution

Irrmischer M, Aqil M, Luan L +5

Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.

O'Connor S, Godfrey K, Reed S +17

LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics.

Shinozuka K, Tewarie PKB, Luppi A +7

Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment

Socoró Garrigosa M, Sanz Perl Y, Kringelbach ML +3

Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexity

Vohryzek J, Garcia Guzman E, Kringelbach ML +8

The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.

Goodwin GM, Aaronson ST, Alvarez O +28

The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State

Coleman CR, Shinozuka K, Tromm R +7

Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.

Shinozuka K, Jerotic K, Mediano P +4

An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.

Godfrey K, Weiss B, Zhang X +5

Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.

Reid MJ, Kettner H, Blanken TF +2

Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.

Jones G, Lowe MX, Nayak S +5

Human brain changes after first psilocybin use

Lyons T, Spriggs M, Kerkelä L +20

Validation of the imperial psychedelic predictor scale.

Angyus M, Osborn S, Haijen E +5

Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.

Erritzoe D, Barba T, Greenway KT +9

Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects.

Martial C, Carhart-Harris R, Timmermann C

Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors

Jiwani Z, Goldberg SB, Stroud J +7

A virtual clinical trial of psychedelics to treat patients with disorders of consciousness

Alnagger NL, Cardone P, Martial C +15

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.

de la Salle S, Kettner H, Thibault Lévesque J +8

Psilocybin desynchronizes the human brain.

Siegel JS, Subramanian S, Perry D +30

Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy.

Roseman L, Erritzoe D, Nutt D +2

Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".

Bornemann J, Close JB, Ahmad K +6

LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics

Shinozuka K, Tewarie PK, Luppi A +7

Psychedelics and the 'inner healer': Myth or mechanism?

Peill J, Marguilho M, Erritzoe D +5

Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.

Erritzoe D, Barba T, Spriggs MJ +3

The Relationship Between Changes in Mindfulness and Subsequent Changes in Well-Being Following Psychedelic Use: Prospective Cohort Study.

Jones G, Herrmann F, Bear A +2

Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.

Copa D, Erritzoe D, Giribaldi B +3

Psychedelics and sexual functioning: a mixed-methods study.

Barba T, Kettner H, Radu C +6

Transient destabilization of whole brain dynamics induced by DMT

Piccinini JI, Perl YS, Pallavicini C +6

Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.

Barbut Siva J, Barba T, Kettner H +4

Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.

Szigeti B, Weiss B, Rosas FE +3

5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?

Dourron HM, Nichols CD, Simonsson O +3

Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology

Shinozuka K, Jerotic K, Mediano P +4

Optimized infusion rates for N,N-dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework.

Eckernäs E, Koomen J, Timmermann C +3

Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.

Dougherty RF, Clarke P, Atli M +10

The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosing.

Szigeti B, Nutt D, Carhart-Harris R +1

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.

Simonsson O, Carlbring P, Carhart-Harris R +5

Pattern breaking: a complex systems approach to psychedelic medicine.

Hipólito I, Mago J, Rosas FE +1

A whole-brain model of the neural entropy increase elicited by psychedelic drugs.

Herzog R, Mediano PAM, Rosas FE +5

Psychological and physiological effects of extended DMT

Luan LX, Eckernäs E, Ashton M +10

PreprintMDMA

Focusing on the negative: cases of long-term negative psychological responses to psychedelics

Bremler R, Katati N, Shergill P +2

N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysis.

Eckernäs E, Timmermann C, Carhart-Harris R +2

LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics.

Ruffini G, Damiani G, Lozano-Soldevilla D +7

Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.

Shukuroglou M, Roseman L, Wall M +3

Predictors Of Hallucinogen Persisting Perception Disorder Symptoms, Delusional Ideation And Magical Thinking Following Naturalistic Psychedelic Use

Zhou K, De Wied D, Carhart-Harris R +1

A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.

Nayak SM, Bari BA, Yaden DB +7

A mechanistic model of the neural entropy increase elicited by psychedelic drugs

Herzog R, Mediano PA, Rosas FE +5

Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trial

Baumann S, Carhart-Harris R, Nutt D +2

Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.

Cruzat J, Perl YS, Escrichs A +10

Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing

Dougherty RF, Clarke P, Alti M +10

Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerations.

Eckernäs E, Timmermann C, Carhart-Harris R +2

Brain dynamics predictive of response to psilocybin for treatment-resistant depression

Vohryzek J, Cabral J, Lord L +6

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.

Barba T, Buehler S, Kettner H +6

LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics

Ruffini G, Damiani G, Lozano-Soldevilla D +7

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.

Watts R, Kettner H, Geerts D +9

Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience.

Lawrence DW, Carhart-Harris R, Griffiths R +1

Phenomenology and Content of the Inhaled N, N-Dimethyltryptamine (N, N-DMT) Experience

Lawrence DW, Carhart-Harris R, Griffiths R +1

Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.

Girn M, Roseman L, Bernhardt B +3

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

Murphy R, Kettner H, Zeifman R +10

Europe PMC2021

Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma.

Eckernäs E, Bendrioua A, Cancellerini C +4